[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Keon et al., 2022 - Google Patents

Cryo-EM of the yeast VO complex reveals distinct binding sites for macrolide V-ATPase inhibitors

Keon et al., 2022

View PDF
Document ID
17837054377126520840
Author
Keon K
Benlekbir S
Kirsch S
Müller R
Rubinstein J
Publication year
Publication venue
ACS Chemical Biology

External Links

Snippet

Vacuolar-type adenosine triphosphatases (V-ATPases) are proton pumps found in almost all eukaryotic cells. These enzymes consist of a soluble catalytic V1 region that hydrolyzes ATP and a membrane-embedded VO region responsible for proton translocation. V-ATPase …
Continue reading at www.biorxiv.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Similar Documents

Publication Publication Date Title
Garcia-Effron Rezafungin—mechanisms of action, susceptibility and resistance: similarities and differences with the other echinocandins
Spadari et al. New approaches for cryptococcosis treatment
Vasanthakumar et al. Structural comparison of the vacuolar and Golgi V-ATPases from Saccharomyces cerevisiae
Lee et al. Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity
Keon et al. Cryo-EM of the yeast VO complex reveals distinct binding sites for macrolide V-ATPase inhibitors
Luo et al. Bedaquiline inhibits the yeast and human mitochondrial ATP synthases
US20040009890A1 (en) Broad spectrum inhibitors
Singh et al. Isolation, characterization and antifungal docking studies of wortmannin isolated from Penicillium radicum
Suchodolski et al. Fluconazole and lipopeptide surfactin interplay during Candida albicans plasma membrane and cell wall remodeling increases fungal immune system exposure
Kuvarina et al. The Emericellipsins A–E from an alkalophilic fungus Emericellopsis alkalina show potent activity against multidrug-resistant pathogenic fungi
Kim et al. Recent development of aminoacyl-tRNA synthetase inhibitors for human diseases: a future perspective
Anjani et al. Inclusion complexes of rifampicin with native and derivatized cyclodextrins: in silico modeling, formulation, and characterization
Niu et al. Structural mechanism of SGLT1 inhibitors
Mishchenko et al. Antiviral potential of sea urchin aminated spinochromes against herpes simplex virus type 1
Tanaka et al. Structural basis for binding of potassium-competitive acid blockers to the gastric proton pump
Alabsi et al. Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried Angiotensin (1—7) Peptide and PNA5 with Trehalose as Microparticles/Nanoparticles for Targeted Respiratory Delivery as Dry Powder Inhalers
Hassan et al. Metals-triggered compound CDPDP exhibits anti-arthritic behavior by downregulating the inflammatory cytokines, and modulating the oxidative storm in mice models with extensive ADMET, docking and simulation studies
Petrou et al. IgA nephropathy: current treatment and new insights
Dreisigacker et al. Understanding the inhibitory effect of highly potent and selective archazolides binding to the vacuolar ATPase
Pitsillou et al. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling
Sheng et al. Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists
Dong et al. Baicalin inhibits the lethality of ricin in mice by inducing protein oligomerization
Park et al. Development of a peptide-based nano-sized cathepsin B inhibitor for anticancer therapy
Nurcahyaningtyas et al. Identification of potential Indonesian marine invertebrate bioactive compounds as TMPRSS2 and SARS-CoV-2 Omicron spike protein inhibitors through computational screening
Boyenle et al. Reinstating apoptosis using putative Bcl-xL natural product inhibitors: Molecular docking and ADMETox profiling investigations